Skip to main content
. 2024 Mar 17;7(2):e00477. doi: 10.1002/edm2.477

TABLE 1.

Characteristics of included studies related the PCOS and IBS.

Author, year, reference Study design Participants PCOS diagnosis criteria IBS diagnosis criteria Findings Quality score
Selection Comparability Exposure Total
Dursun et al. (2018) [19] Case–control

Patients with PCOS (n = 54)

Controls (n = 53)

Revised 2003 Rotterdam criteria Rome III criteria Prevalence of IBS was 39% in PCOS patients vs 19% in control 2 1 2 5
Mathur et al. (2010) [20] Case–control

Patients with PCOS (n = 36)

Controls (n = 29)

NIH 1990 Bowel‐related questions Prevalence of IBS was 41.7% in PCOS patients vs 10.3% in control 4 2 6
Kałużna et al. (2022) [6] Case–control

Patients with PCOS (n = 133)

Controls (n = 72)

ESHRE guideline Rome IV criteria Prevalence of IBS was 24% (32/133) in PCOS patients vs. 21% in control (15/72) (p = 0.60) 3 2 3 8
Bazarganipour et al. (2020) [14] Case–control

Patients with PCOS (n = 101)

Controls (n = 100)

Rotterdam diagnostic criteria Rome III criteria IBS symptoms were higher in PCOS (20.7%) than control group (11%) (p = 0.05). 3 3 6
Tseng et al. (2020) [17] Case–control

Patients with PCOS (n = 431)

Controls (n = 259)

Rotterdam diagnostic criteria Rome III criteria Women with PCOS were more likely to have IBS (10.7% vs. 5.8%, p = 0.029) and obesity (29% vs. 4%, p < 0.001) than healthy volunteers. Mixed‐type IBS (IBS‐M) was the most common subtype (74%) among patients with PCOS and IBS. 3 3 6
Naziye Gürkan et al. (2022) [7] Case–control Women with PCOS (n = 38) and control group (n = 34) Rotterdam Criteria Roma IV IBS prevalence was similar in PCOS (52%) and the control group (50%). 3 2 5

Abbreviations: ESHRE, European Society of Human Reproduction and Embryology; IBS, irritable bowel syndrome; NIH, National Institutes of Health; PCOS, polycystic ovary syndrome.